As a company listed on the Euronext Growth market in Paris, Europlasma undertakes to providing the financial community with regular, transparent and accessible information and in compliance with stock market regulations
Europlasma announces that its 2017 Registration Document ("Document de Référence 2017") has been filed today with the "Autorité des Marchés Financiers" (AMF) under the number D.18-0436.
Europlasma today announces its results for the year ended December 31, 2017, approved by the Board of Directors on April 17, 2018 and audited by the Auditors.
In accordance with the bond financing agreement and the schedule published, the third warrant of convertible bonds into shares (BEOCA) has been automatically exercised by the investor, European High Growth Opportunities Securitization Fund.
